US 7772250
Compounds
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7772250 (Compounds) held by Theravance, Inc. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P15/06